Keep your eye on the Prize! An equally important question is what might happen when 2020 rolls around. According to Wall Street, the dispensary operator that could give Curaleaf the biggest run for its money is Cresco Labs(NASDAQOTH:CRLBF). Even though Cresco Labs holds fewer than five dozen retail licenses in close to a dozen states, it's in the process of acquiring Origin House for what was announced as an $823 million all-stock deal. As one of the few holders of cannabis distribution licenses in California, Cresco Labs will be able to use Origin House to place its in-house-branded pot products into more than 500 California dispensaries. The $711 million in sales forecast by Wall Street in 2020 could be a high-water mark among U.S. dispensary stocks.
Suffice it to say, with acquisition activity not slowing, investors should expect the U.S. dispensary space to remain fluid.
Ref: https://www.fool.com/investing/2019/07/20/a-comprehensive-look-at-us-dispensary-stocks-follo.aspx